Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of New-Generation Bioabsorbable Scaffolds Versus Drug-Coated Balloons in the Treatment of De Novo Lesions in Large Coronary Arteries: A Prospective Randomized Controlled Study

NCT07162792 is registered in ClinicalTrials.gov with Xuzhou Third People's Hospital as lead sponsor.

NCT NCT07162792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07162792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of New-Generation Bioabsorbable Scaffolds Versus Drug-Coated Balloons in the Treatment of De Novo Lesions in Large Coronary Arteries: A Prospective Randomized Controlled Study
Lead sponsor
Xuzhou Third People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 23, 2025
Completion date
December 30, 2028
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease(cad), de novo coronary lesions